共 20 条
[1]
Lrp1 in osteoblasts controls osteoclast activity and protects against osteoporosis by limiting PDGF–RANKL signaling.[J].Alexander Bartelt;Friederike Behler-Janbeck;F.Timo Beil;Till Koehne;Brigitte Müller;Tobias Schmidt;Markus Heine;Laura Ochs;Tayfun Yilmaz;Martin Dietrich;Jan P. Tuckermann;Michael Amling;Joachim Herz;Thorsten Schinke;Joerg Heeren;Andreas Niemeier;.Bone Research.2018, 01
[2]
[3]
Association of interleukin-6 (rs1800796) but not transforming growth factor beta 1 (rs1800469) with serum calcium levels in osteoporotic patients.[J].Hajar Eftekhari;Seyyed Reza Hosseini;Hadis Pourreza Baboli;Maryam Mafi Golchin;Laleh Heidari;Zeinab Abedian;Roghayeh Pourbagher;Fatemeh Amjadi-Moheb;Seyyedeh Narges Mousavi Kani;Hajighorban Nooreddini;Haleh Akhavan-Niaki.Gene.2018,
[4]
Tanshinone?IIA attenuates the deleterious effects of oxidative stressin osteoporosis through the NF?κB signaling pathway.[J].Shaowen Zhu;Wanfu Wei;Zhiwei Liu;Yang Yang;Haobo Jia.Molecular Medicine Reports.2018, 5
[6]
Postmenopausal osteoporosis in rheumatoid arthritis: The estrogen deficiency-immune mechanisms link.[J].Rony Sapir-Koren;Gregory Livshits.Bone.2017,
[8]

